No Data
Special Treat Guangwang (600831.SH): Plans to cancel the holding subsidiary Guangdian Health.
On January 7, Longtu Finance reported that Special Treat Guangwang (600831.SH) announced that the Board of Directors authorized the management to dispose of equity in some underperforming holding subsidiaries with poor development prospects, as well as in associated companies with low relevance and weak control capacity. To this end, the company's holding subsidiary Shaanxi Guangdian Huating Investment Holding Co., Ltd. (referred to as "Guangdian Huating") is liquidating and deregistering its holding company Shaanxi Guangdian Health Industry Co., Ltd. (referred to as "Guangdian Health"). Recently, Guangdian Health received the Deregistration Notification from the Data and Administrative Approval Service Bureau of Lianhu District, Xi'an City, approving the deregistration.
Zhejiang Garden Biopharmaceutical (300401.SZ): Plans to establish a subsidiary in Macau to engage in the research, production, and sales of health-related products.
On December 31, Gelonghui reported that Zhejiang Garden Biopharmaceutical (300401.SZ) announced plans to establish a subsidiary in Macau to expand its domestic and international markets and enhance the company's brand influence and market competitiveness. The establishment of a subsidiary in Macau aims to leverage Macau's international platform, expand both domestic and overseas markets, and enhance the company's brand influence and market competitiveness. Additionally, Macau has a solid industrial foundation and favorable policy environment for the research and development, production, and sales of big health products, which is beneficial for the company's big health business development.
Berry Genomics (000710.SZ) subsidiary plans to invest 26.8 million yuan in Fuzhou Xintou Zhi Kai Ruikang, focusing on the Medical and health sector.
Berry Genomics (000710.SZ) announced that its wholly-owned subsidiary Fujian Berry Health and Genetic Technologies Co., Ltd. (abbreviated...
Shanghai Runda Medical Technology (603108.SH) plans to participate in the establishment of Fuzhou New Investment Zhikai Ruikang Venture Capital Fund, mainly investing in the medical and health sector.
Shanghai Runda Medical Technology (603108.SH) released an announcement, stating that the company plans to collaborate with Shanghai Zhikai Asset Management Co., Ltd. (abbreviated as "...")
How can the results of major health research be translated into practice? This forum, gathering Medical Institutions, entrepreneurs, investment Institutions, and Universities, is here.
The forum on the transformation of scientific achievements in the big health industry, co-hosted by the Antai College of Economics and Management at Shanghai Jiao Tong University and the Zhongyin Technology Finance College at Shanghai Jiao Tong University, was held at the Shanghai Machinery Valley Industrial Park. Guests from Medical institutions, investment Institutions, and Universities' research institutes discussed the transformation of scientific achievements in the big health industry.
Universal Health International Group Holding Limited's (HKG:2211) Price Is Right But Growth Is Lacking After Shares Rocket 75%
